Literature DB >> 10099258

Removal of proteoglycans increases efficiency of retroviral gene transfer.

J M Le Doux1, J R Morgan, M L Yarmush.   

Abstract

We have previously shown that medium conditioned by virus producer cells inhibits retrovirus transduction, and that a portion of the inhibitory activity is sensitive to chondroitinase ABC. In this study, we have quantitatively evaluated the fraction of the inhibitory activity that is due to chondroitinase ABC-sensitive material and partially characterized the inhibitors. The kinetics of chondroitinase ABC digestion of glycosaminoglycans and virus inhibitory activity in cell culture medium were measured, and the results used to estimate the amount of the chondroitinase ABC-sensitive virus inhibitory activity that was initially in the medium. We found that up to 76% of the inhibitory activity of medium conditioned by packaging cells derived from NIH 3T3 cells is sensitive to chondroitinase ABC. The remainder of the inhibitory activity is not sensitive to other glycosaminoglycan lyases (heparitinase I or heparinase I), which suggests that substances other than glycosaminoglycans or proteoglycans are present in virus stocks and inhibit transduction. To further characterize the inhibitors, proteoglycans from conditioned medium were purified by batch anion exchange and size exclusion chromatography. Two major size groups (100 kDa and 950 kDa) of proteoglycans were isolated. Transduction was inhibited 50% by 0.6 microg/mL of the high-molecular-weight proteoglycan or by 1.7 microg/mL of the low-molecular-weight proteoglycan. Significantly, the proteoglycans, because of their large size and poor sieving properties, coconcentrated with virus particles concentrated by ultrafiltration and prevented any significant increases in transduction efficiency. Transduction efficiencies of virus stocks were increased more than tenfold by ultrafiltration, but only when the concentrated virus was treated with chondroitinase ABC. Copyright 1998 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10099258     DOI: 10.1002/(sici)1097-0290(19980405)58:1<23::aid-bit3>3.3.co;2-s

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  5 in total

1.  Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.

Authors:  Nina Dmitrieva; Lianbo Yu; Mariano Viapiano; Timothy P Cripe; E Antonio Chiocca; Joseph C Glorioso; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2010-12-21       Impact factor: 12.531

2.  Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography.

Authors:  Kaiming Ye; Sha Jin; Mohammad M Ataai; Jerome S Schultz; Jeanette Ibeh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 3.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

Review 4.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

5.  A novel use of TAT-EGFP to validate techniques to alter osteosarcoma cell surface glycosaminoglycan expression.

Authors:  Arjuna Kumarasuriyar; Christian Dombrowski; David A Rider; Victor Nurcombe; Simon M Cool
Journal:  J Mol Histol       Date:  2007-09-21       Impact factor: 3.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.